The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update.

about

The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update.

Item

http://www.wikidata.org/entity/Q36411193

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The University College London/ ...... sment PROMIS Trial: An Update.

@ast

The University College London/ ...... sment PROMIS Trial: An Update.

@en

type

Item

label

The University College London/ ...... sment PROMIS Trial: An Update.

@ast

The University College London/ ...... sment PROMIS Trial: An Update.

@en

prefLabel

The University College London/ ...... sment PROMIS Trial: An Update.

@ast

The University College London/ ...... sment PROMIS Trial: An Update.

@en

P1476

The University College London/ ...... sment PROMIS Trial: An Update.

@en

P2093

Ahmed El-Shater Bosaily

http://www.w3.org/2001/XMLSchema#string

Christopher Parker

http://www.w3.org/2001/XMLSchema#string

Hashim U Ahmed

http://www.w3.org/2001/XMLSchema#string

Louise C Brown

http://www.w3.org/2001/XMLSchema#string

Rhian Gabe

http://www.w3.org/2001/XMLSchema#string

Richard G Hindley

http://www.w3.org/2001/XMLSchema#string

Richard Kaplan

http://www.w3.org/2001/XMLSchema#string

P2860

ESUR prostate MR guidelines 2012

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer?

PROMIS--Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer.

How good is MRI at detecting and characterising cancer within the prostate?

Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen.

Is it time to consider a role for MRI before prostate biopsy?

The role of magnetic resonance imaging in delineating clinically significant prostate cancer

Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard.

Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard.

Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.

P304

212-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EUF.2015.04.007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

PROMIS Cooperative Group

Mark Emberton

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26839919

http://www.w3.org/2001/XMLSchema#string

P932

4694096

http://www.w3.org/2001/XMLSchema#string